Orakl Oncology
Techbio platform leveraging the smartest collection of tumour avatars to transform oncology drug development
Orakl Oncology has raised €14M across 2 funding rounds from 7 investors, most recently a Seed round in Dec 2024. Based in Villejuif, France; active in Healthtech. Data as of 28 Oct 2026.
Villejuif, Francewww.orakl-oncology.com ↗
Total raised
€14M
€14,000,000
Funding rounds
2
Investors
7
distinct backers
Active since
2023-10
latest 2024-12
Funding by year
EUR raised per yearOrakl Oncology — funding by year — interactive chart.
Data table
| Orakl Oncology — funding by year | |
|---|---|
| 2023 | €3.0M |
| 2024 | €11M |
Signals
High confidenceRaise-next likelihood37
base rate 44% for Seed
- ▼ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-12-03 | Seed | €11M | Bpifrance,Existing investors,Grand Prix i-Lab,Singular | View deal → |
| 2023-10-05 | Other | €3.0M | HCVC,Speedinvest,Verve Ventures | View deal → |
Investors
7Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData